IQVIA Holdings Inc.

IQVIA Holdings Inc. (NYSE: IQV) is a premier global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries, operating in over 100 countries with approximately 93,000 employees and generating over $15 billion in revenue in FY2024. Headquartered in Durham, North Carolina, the company operates through three core segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions, serving pharmaceutical, biotechnology, medical device, and consumer health clients across the Americas, Europe, Africa, and Asia-Pacific. IQVIA's competitive edge is anchored by its proprietary IQVIA CORE platform, which leverages more than 1.2 billion de-identified patient records, Healthcare-grade AI, and real-world evidence capabilities to accelerate drug development and commercialization. Founded in 1982 and formerly known as Quintiles IMS Holdings, Inc., the company rebranded as IQVIA Holdings in November 2017 following the landmark merger of Quintiles and IMS Health, and is led by Chairman and CEO Ari Bousbib.